The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Mitogen-Activated Protein Kinases and Their Role in Radiation Response
Open accessAbstract
Ionizing radiation, like a variety of other cellular stress factors, can activate or down-regulate multiple signaling pathways, leading to either increased cell death or increased cell proliferation. Modulation of the signaling process, however, depends on the cell type, radiation dose, and culture conditions. The mitogen-activated protein kinase (MAPK) pathway transduces signals from the cell membrane to the nucleus in response to a variety of different stimuli and participates in various intracellular signaling pathways that control a wide spectrum of cellular processes, including growth, differentiation, and stress responses, and is known to have a key role in cancer progression. Multiple signal transduction pathways stimulated by ionizing radiation are mediated by the MAPK superfamily including the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK. The ERK pathway, activated by mitogenic stimuli such as growth factors, cytokines, and phorbol esters, plays a major role in regulating cell growth, survival, and differentiation. In contrast, JNK and p38 MAPK are weakly activated by growth factors but respond strongly to stress signals including tumor necrosis factor (TNF), interleukin-1, ionizing and ultraviolet radiation, hyperosmotic stress, and chemotherapeutic drugs. Activation of JNK and p38 MAPK by stress stimuli is strongly associated with apoptotic cell death. MAPK signaling is also known to potentially influence tumor cell radiosensitivity because of their activity associated with radiation-induced DNA damage response. This review will discuss the MAPK signaling pathways and their roles in cellular radiation responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., Demidov, L. V., Hassel, J. C., Rutkowski, P., Mohr, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203421 · Cited by 2,160
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Verheij, M., Bose, R., Hua Lin, X., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., et al. (1996) · Nature · doi:10.1038/380075a0 · Cited by 1,767
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369 · cited 1×
“Preclinical observations made with a JNK inhibitor (SP600125) are likely to be less informative regarding the biological roles of JNK due to the considerable off-target activity of this compound.(42) One JNK inhibitor, CC-401, is however in phase II evaluations in acute myelogenous leukemia and has also been considere…”
BackgroundBRAF mutation predicts sensitivity to MEK inhibition
Solit, D. B., Garraway, L. A., Pratilas, C. A., Sawai, A., Getz, G., Basso, A., Ye, Q., Lobo, J. M., She, Y., Osman, I., et al. (2006) · Nature · doi:10.1038/nature04304 · Cited by 1,328
Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B., & Davis, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1247 · Cited by 1,278
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
Lei, K., & Davis, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438011100 · Cited by 1,068
Deak, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4426 · Cited by 993
Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., et al. (1999) · PubMed · Cited by 947
Mutagenesis by 8-oxoguanine: an enemy within
Grollman, A. P., & Moriya, M. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90089-z · Cited by 807 · cited 1×
“c-Jun also interacts physically or functionally with 2 proteins involved in DNA repair: redox factor 1 (also known as APEX), an endonuclease specific for abasic sites,(37) and thymine DNA glycosylase,(38) both of which are involved in base excision repair, which is responsible for the repair of modified lesions on DNA…”
BackgroundIdentification of a Dual Specificity Kinase That Activates the Jun Kinases and p38-Mpk2
Lin, A., Minden, A., Martinetto, H., Claret, F.-X., Lange-Carter, C., Mercurio, F., Johnson, G. L., & Karin, M. (1995) · Science · doi:10.1126/science.7716521 · Cited by 764
Mitogen-activated protein kinase cascades and regulation of gene expression
Su, B., & Karin, M. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80131-2 · Cited by 747
Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)
Byrne, A. M., Bouchier-Hayes, D. J., & Harmey, J. H. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00379.x · Cited by 744
De Luca, A., Maiello, M. R., D'Alessio, A., Pergameno, M., & Normanno, N. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.639361 · Cited by 735
Xanthoudakis, S., & Curran, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05097.x · Cited by 708
Rinehart, J., Adjei, A. A., LoRusso, P. M., Waterhouse, D., Hecht, J. R., Natale, R. B., Hamid, O., Varterasian, M., Asbury, P., Kaldjian, E. P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.185 · Cited by 645
The stress-activated protein kinase pathways
Tibbles, L. A., & Woodgett, J. R. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050369 · Cited by 643
MAPK pathways in radiation responses
Dent, P., Yacoub, A., Fisher, P. B., Hagan, M. P., & Grant, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206701 · Cited by 602
Targeting JNK for therapeutic benefit: from junk to gold?
Manning, A. M., & Davis, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1132 · Cited by 585
Infante, J. R., Fecher, L. A., Falchook, G. S., Nallapareddy, S., Gordon, M. S., Becerra, C., DeMarini, D. J., Cox, D. S., Xu, Y., Morris, S. R., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70270-x · Cited by 552
Falchook, G. S., Lewis, K. D., Infante, J. R., Gordon, M. S., Vogelzang, N. J., DeMarini, D. J., Sun, P., Moy, C., Szabo, S. A., Roadcap, L. T., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70269-3 · Cited by 546
Chevray, P. M., & Nathans, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5789 · Cited by 525
Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways1
Dent, P., Yacoub, A., Contessa, J., Caron, R., Amorino, G., Valerie, K., Hagan, M. P., Grant, S., & Schmidt-Ullrich, R. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0283:sariao]2.0.co;2 · Cited by 463
Lei, K., Nimnual, A., Zong, W.-X., Kennedy, N. J., Flavell, R. A., Thompson, C. B., Bar-Sagi, D., & Davis, R. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4929-4942.2002 · Cited by 463
Persistent Activation of c-Jun N-terminal Kinase 1 (JNK1) in γ Radiation-induced Apoptosis
Chen, Y.-R., Meyer, C. F., & Tan, T.-H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.631 · Cited by 459
Wiggin, G. R., Soloaga, A., Foster, J. M., Murray-Tait, V., Cohen, P., & Arthur, J. S. C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2871-2881.2002 · Cited by 445
Targeting the ERK signaling pathway in cancer therapy
Kohno, M., & Pouyssegur, J. (2006) · Annals of Medicine · doi:10.1080/07853890600551037 · Cited by 416
The role of mitogen-activated protein (MAP) kinase in breast cancer
Santen, R. J., Song, R. X., McPherson, R., Kumar, R., Adam, L., Jeng, M.-H., & Yue, W. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00189-3 · Cited by 406
LoRusso, P. M., Adjei, A. A., Varterasian, M., Gadgeel, S., Reid, J., Mitchell, D. Y., Hanson, L., DeLuca, P., Bruzek, L., Piens, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.415 · Cited by 401
The ras Oncogenes Increase the Intrinsic Resistance of NIH 3T3 Cells to Ionizing Radiation
Sklar, M. D. (1988) · Science · doi:10.1126/science.3277276 · Cited by 354
Signal Transduction and Cellular Radiation Responses
Schmidt-Ullrich, R. K., Dent, P., Grant, S., Mikkelsen, R. B., & Valerie, K. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0245:stacrr]2.0.co;2 · Cited by 316
Targeting signal transduction as a strategy to treat inflammatory diseases
O'Neill, L. A. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2070 · Cited by 283
MEK1/2 dual-specificity protein kinases: Structure and regulation
Roskoski, R. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.145 · Cited by 276
Involvement of the MKK6-p38γ Cascade in γ-Radiation-Induced Cell Cycle Arrest
Wang, X., McGowan, C. H., Zhao, M., He, L., Downey, J. S., Fearns, C., Wang, Y., Huang, S., & Han, J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4543-4552.2000 · Cited by 249
Kim, S.-J., Ju, J.-W., Oh, C.-D., Yoon, Y.-M., Song, W. K., Kim, J.-H., Yoo, Y. J., Bang, O.-S., Kang, S.-S., & Chun, J.-S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107231200 · Cited by 241
Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M. J., Gjerset, R., & Mercola, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14041 · Cited by 229
Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
Brown, P. H., Alani, R. M., Preis, L. H., Szabo, E. M., & Birrer, M. J. (1993) · PubMed · Cited by 224
Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.
Wang, Y., Li, J., Booher, R. N., Kraker, A. J., Lawrence, T. S., Leopold, W. R., & Sun, Y. (2001) · PubMed · Cited by 210
Golding, S. E., Morgan, R. N., Adams, B. R., Hawkins, A. J., Povirk, L. F., & Valerie, K. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.8.7927 · Cited by 202
Golding, S. E., Rosenberg, E., Neill, S., Dent, P., Povirk, L. F., & Valerie, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2371 · Cited by 189
Kasid, U., Pfeifer, A., Brennan, T., Beckett, M., Weichselbaum, R. R., Dritschilo, A., & Mark, G. E. (1989) · Science · doi:10.1126/science.2466340 · Cited by 186
Kim, I.-A., Bae, S.-S., Fernandes, A., Wu, J., Muschel, R. J., McKenna, W. G., Birnbaum, M. J., & Bernhard, E. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0513 · Cited by 179
Bernhard, E. J., Stanbridge, E. J., Gupta, S., Gupta, A. K., Soto, D. E., Bakanauskas, V. J., Cerniglia, G. J., Muschel, R. J., & McKenna, W. G. (2000) · PubMed · Cited by 172
ATM-Dependent Phosphorylation of ATF2 Is Required for the DNA Damage Response
Bhoumik, A., Takahashi, S., Breitweiser, W., Shiloh, Y., Jones, N., & Ronai, Z. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.015 · Cited by 172
p38 and Chk1 kinases: different conductors for the G2/M checkpoint symphony
Bulavin, D. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00270-2 · Cited by 172
Vascular Endothelial Growth Factor Enhances Endothelial Cell Survival and Tumor Radioresistance
Gupta, V. K., Jaskowiak, N. T., Beckett, M. A., Mauceri, H. J., Grunstein, J., Johnson, R. S., Calvin, D. A., Nodzenski, E., Pejovic, M., Kufe, D. W., et al. (2002) · The Cancer Journal · doi:10.1097/00130404-200201000-00009 · Cited by 170
Determination of cell fate by c-Abl activation in the response to DNA damage
Kharbanda, S., Yuan, Z.-M., Weichselbaum, R., & Kufe, D. (1998) · Oncogene · doi:10.1038/sj.onc.1202571 · Cited by 168
p38 MAP kinase inhibitors: many are made, but few are chosen.
Dominguez, C., Powers, D. A., & Tamayo, N. A. (2005) · PubMed · Cited by 163
Hayakawa, J., Depatie, C., Ohmichi, M., & Mercola, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210992200 · Cited by 159
Yosimichi, G., Nakanishi, T., Nishida, T., Hattori, T., Takano‐Yamamoto, T., & Takigawa, M. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02553.x · Cited by 158
The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts.
Bernhard, E. J., Kao, G. D., Cox, A. D., Sebti, S. M., Hamilton, A. D., Muschel, R. J., & McKenna, W. G. (1996) · PubMed · Cited by 155
Activation of Raf by ionizing radiation
Kasid, U. N., Suy, S., Dent, P., Ray, S., Whiteside, T. L., & Sturgill, T. W. (1996) · Nature · doi:10.1038/382813a0 · Cited by 153
Park, J. S., Qiao, L., Su, Z.-Z., Hinman, D., Willoughby, K. A., McKinstry, R. P., Yacoub, A., Duigou, G. J., Young, C. S. H., Grant, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204258 · Cited by 139
Abbott, D. W., & Holt, J. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2732 · Cited by 138
Radiation-Induced Signal Transduction and Stress Response
Haimovitz‐Friedman, A. (1998) · Radiation Research · doi:10.2307/3579812 · Cited by 138
Protective Role for c-Jun in the Cellular Response to DNA Damage
Potapova, O., Basu, S., Mercola, D., & Holbrook, N. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102075200 · Cited by 121
Scherer, S. J., Maier, S. M., Seifert, M., Hanselmann, R. G., Zang, K. D., Müller‐Hermelink, H. K., Angel, P. E., Welter, C., & Schartl, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006990200 · Cited by 108
Stadheim, T. A., & Kucera, G. L. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00099-6 · Cited by 106
Syljuåsen, R. G., Sørensen, C. S., Nylandsted, J., Lukas, C., Lukas, J., & Bartek, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2434 · Cited by 99
Verheij, M., Ruiter, G. A., Zerp, S. F., BLITTERSWIJK, W. J. V., FUKS, Z. Y., Haimovitz‐Friedman, A., & Bartelink, H. G. M. M. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00007-3 · Cited by 93
Choi, S.-Y., Kim, M., Kang, C., Bae, S., Cho, C.-K., Soh, J., Kim, J., Kang, S., Chung, H. Y., Lee, Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512000200 · Cited by 93
Chung, E. J., Brown, A. P., Asano, H., Mandler, M. D., Burgan, W. E., Carter, D., Camphausen, K. A., & Citrin, D. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2954 · Cited by 91
Marampon, F., Gravina, G. L., Rocco, A. D., Bonfili, P., Staso, M. D., Fardella, C., Polidoro, L., Ciccarelli, C., Festuccia, C., Popov, V. M., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0631 · Cited by 87
Williams, T. M., Flecha, A. R., Keller, P., Ram, A. N., Karnak, D. M., Galbán, S., Galbán, C. J., Ross, B. D., Lawrence, T. S., Rehemtulla, A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0098 · Cited by 81
Deciphering the MAP kinase pathway
L’Allemain, G. (1994) · Progress in Growth Factor Research · doi:10.1016/0955-2235(94)90011-6 · Cited by 80
βPix-enhanced p38 Activation by Cdc42/Rac/PAK/MKK3/6-mediated Pathway
Lee, S.-H., Eom, M., Lee, S. J., Kim, S., Park, H.-J., & Park, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010892200 · Cited by 78
Ferrer, I., Olivé, M., Ribera, J., & Planas, A. M. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01297.x · Cited by 78
Eriksson, D., Löfroth, P., Johansson, L. F., Riklund, K., & Stigbrand, T. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0980 · Cited by 77
MacLaren, A., Black, E. J., Clark, W. A., & Gillespie, D. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9006-9018.2004 · Cited by 74
Small Molecule p38 Inhibitors: Novel Structural Features and Advances from 2002-2005
Hynes, J. J., & Leftheris, K. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054985920 · Cited by 70
Kurland, J. F., Voehringer, D. W., & Meyn, R. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212919200 · Cited by 70
Lee, S. A., Dritschilo, A., & Jung, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004517200 · Cited by 64
Wg, M., Bernhard, E. J., Markiewicz, D. A., Rudoltz, M. S., Maity, A. M., & Muschel, R. J. (1996) · PubMed · Cited by 62
Signaling events controlling the molecular response to genotoxic stress
Holbrook, N. J., Liu, Y., & Fornace, A. J. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9088-5_18 · Cited by 60
Juretić, N., Santibanez, J. F., Hurtado, C., & Martı́nez, J. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1211 · Cited by 59
Maizels, E. T., Mukherjee, A., Sithanandam, G., Peters, C. A., Cottom, J. E., Mayo, K. E., & Hunzicker-Dunn, M. E. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.5.0634 · Cited by 59
Ferrer, I., Olivé, M., Blanco, R. E., Cinós, C., & Planas, A. M. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00334-o · Cited by 57
Sambade, M. J., Camp, J. T., Kimple, R. J., Sartor, C. I., & Shields, J. M. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.09.006 · Cited by 56
Li, J., Wang, Y., Sun, Y., & Lawrence, T. S. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0322:wttigp]2.0.co;2 · Cited by 55
Therapeutics targeting signal transduction for patients with colorectal carcinoma
Bono, J. S. D., & Rowinsky, E. K. (2002) · British Medical Bulletin · doi:10.1093/bmb/64.1.227 · Cited by 55
Shannon, A. M., Telfer, B. A., Smith, P. D., Babur, M., Logié, A., Wilkinson, R. W., Debray, C., Stratford, I. J., Williams, K. J., & Wedge, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2958 · Cited by 54
Lee, Y., Soh, J., Dean, N. M., Cho, C.-K., Kim, T., Lee, S., & Lee, Y. (2002) · PubMed · Cited by 53
Abnormal Cytokinesis after X-Irradiation in Tumor Cells that Override the G2 DNA Damage Checkpoint
Huang, H., Fletcher, L., Beeharry, N., Daniel, R., Kao, G. D., Yen, T. J., & Muschel, R. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0479 · Cited by 43
Weizman, N., Shiloh, Y., & Barzilai, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211168200 · Cited by 40
Viktorsson, K., Ekedahl, J., Lindebro, M. C., Lewensohn, R., Zhivotovsky, B., Linder, S. T., & Shoshan, M. C. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00264-7 · Cited by 40
Kim, M., Choi, S.-Y., Park, I., Hwang, S., Kim, C., Choi, Y.-H., Kim, H., Lee, K.-H., & Lee, S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0032 · Cited by 40
Hyperosmotic stress activates the insulin receptor in CHO cells
Ouwens, D. M., de Mesquita, D. S. G., Dekker, J., & Maassen, J. A. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00126-4 · Cited by 34
The Role of Mitogen-Activated ERK-Kinase Inhibitors in Lung Cancer Therapy
Adjei, A. A. (2005) · Clinical Lung Cancer · doi:10.3816/clc.2005.n.040 · Cited by 34
Wei, F., Yan, J., Tang, D., Lin, X., He, L., Xie, Y., Tao, L., & Wang, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.016 · Cited by 31
Gjerset, R. A., Lebedeva, S., Haghighi, A. P., Turla, S. T., & Mercola, D. (1999) · PubMed · Cited by 30
Correlation between γ-ray-induced G2 arrest and radioresistance in two human cancer cells
Tamamoto, T., Ohnishi, K., Takahashi, A., Wang, X., Yosimura, H., Ohishi, H., Uchida, H., & Ohnishi, T. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00072-3 · Cited by 29
Kim, M., Lee, K., & Lee, S. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06363.x · Cited by 24
Cited by
Khoo, H. E., Azlan, A., Tang, S. T., & Lim, S. M. (2017) · Food & Nutrition Research · doi:10.1080/16546628.2017.1361779 · Cited by 2,969
RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression
Rezatabar, S., Karimian, A., Rameshknia, V., Parsian, H., Majidinia, M., Kopi, T. A., Bishayee, A., Sadeghinia, A., Yousefi, M., Monirialamdari, M., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28334 · Cited by 340
Mehta, M., Dhanjal, D. S., Paudel, K. R., Singh, B., Gupta, G., Rajeshkumar, S., Thangavelu, L., Tambuwala, M. M., Bakshi, H. A., Chellappan, D. K., et al. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00698-3 · Cited by 330
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer
Talero, E., García-Mauriño, S., Ávila-Román, J., Rodríguez-Luna, A., Alcaide, A., & Motilva, V. (2015) · Marine Drugs · doi:10.3390/md13106152 · Cited by 255
Radiation-induced signaling pathways that promote cancer cell survival (Review)
HEIN, A. L., OUELLETTE, M. M., & YAN, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2614 · Cited by 201
Metadata
- Authors
- Munshi, A., & Ramesh, R.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2013-04-09
- Volume
- 4
- Issue
- 9-10
- Pages
- 401-408
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- OpenAlex
- W2139737762
- Cited by
- 322
- References
- 96
- FWCI
- 20.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.